Cell Source Inc CLCS
Trading Information
- Previous Close Price
- $0.40
- Day Range
- $0.46–0.53
- 52-Week Range
- $0.25–2.25
- Bid/Ask
- $0.28 / $0.55
- Shares Outstanding
- 67.95M
- Market Cap
- $36.00M
- Volume/Avg
- 750 / 3,432
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Cell Source Inc is a biotechnology company focused on developing cell therapy treatments focused on immunotherapy. The company is involved with the development of proprietary immune system management technology. The company's subsidiary commercializes a suite of inventions relating to certain cancer treatments. The other products include Anti-rejection Veto Cell tolerance therapy for both matched and mismatched allogeneic bone marrow transplantations and Anti-rejection Veto Cell tolerance therapy for both matched as well as mismatched organ transplantation.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- —
- Total Number of Employees
- 0
- Website
- https://www.cell-source.com
Valuation
|
Metric
|
CLCS
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
CLCS
|
|---|---|
Quick Ratio | 0.01 |
Current Ratio | 0.02 |
Interest Coverage | −3.15 |
Quick Ratio
CLCS
Profitability
|
Metric
|
CLCS
|
|---|---|
Return on Assets (Normalized) | −1,843.24% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
CLCS
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|P!b$@J | LOCK|WDptx | $133B | |||
| Moderna Inc
MRNA
| LOCK|zt<??l? | LOCK|ZZ# | $98B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|<qss&n? | LOCK|<<CJ | $83B | |||
| argenx SE ADR
ARGX
| LOCK|<DJz!! | LOCK|<JY | $56B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|&!$bNg | LOCK|G^ | $45B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|#SBrJY! | LOCK|LffT | $30B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|c#$HB&^ | LOCK|q&r% | $28B | |||
| Incyte Corp
INCY
| LOCK|F<lR<%X | LOCK|?% | $23B | |||
| BioNTech SE ADR
BNTX
| LOCK|<p#lq$ | LOCK|%Y | $23B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|Jxw#FM | LOCK|>L | $14B |
United States